Orient Pharma Co., Ltd. (TPEX:4166)
Taiwan
· Delayed Price · Currency is TWD 24.70
+0.40 (1.65%)
At close: Dec 5, 2025
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2010 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2010 - 2019 |
| Factory Operations | 1.16B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Factory Operations Growth | 37.28% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Global Business | 59.92M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Global Business Growth | 53.57% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Medical Affairs | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Medical Affairs Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2010 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2010 - 2019 |
| Taiwan | 826.45M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Taiwan Growth | 21.57% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| United States | 325.38M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| United States Growth | 82.30% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| China | 34.43M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| China Growth | 191155.56% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Philippines | 13.25M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Philippines Growth | -44.34% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other | 23.31M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Growth | 199.00% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Ireland | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Ireland Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| China and Others | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| China and Others Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|